Clinical services have returned to regular, pre-pandemic capacity at Washtenaw County Health Department.

A nurse holds vials of the Pfizer-BioNTech vaccine above a deep freeze cooler at Michigan Stadium on Dec. 31, 2020. ANN ARBOR – Michigan Medicine announced in an email to staff on Monday that it has expanded the Phase 1A COVID-19 vaccine priority group after administering more than 11,000 vaccines since Dec. 14. Based on recommendations from the state, those now eligible for a Phase 1A vaccine at University of Michigan include:Anyone serving in a role at Michigan Medicine or University of Michigan who works in a clinical setting (i.e. hospital, ambulatory clinic, home care) and is not able to work exclusively remotely is able to receive a COVID-19 vaccine now as part of Phase 1A. Michigan Medicine is administering vaccines seven days a week.